Phathom Pharmaceuticals Inc (PHAT)
4.86 +0.45 (+10.20%) 14:37 ET [NASDAQ]
4.85 x 200 4.87 x 100
Realtime by (Cboe BZX)
4.85 x 200 4.87 x 100
Realtime 4.44 +0.03 (+0.68%) 08:59 ET
for Mon, Mar 17th, 2025
Fiscal Year End Date: 12/31
12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
Operating Expenses | 106,215 | 1,225 | 0 | 0 | 0 |
Operating Income | -106,215 | -1,225 | N/A | N/A | N/A |
Interest Expense | 4,177 | 13 | 0 | 0 | 0 |
Other Income | -144,739 | -50 | 0 | 0 | 0 |
Pre-tax Income | -255,131 | -1,288 | 0 | 0 | 0 |
Net Income Continuous | -255,131 | -1,288 | N/A | N/A | N/A |
Net Income | $-255,131 | $-1,288 | $N/A | $N/A | $N/A |
EPS Basic Total Ops | -22.45 | -0.21 | N/A | N/A | N/A |
EPS Basic Continuous Ops | -22.44 | -0.21 | N/A | N/A | N/A |
EPS Diluted Total Ops | -22.45 | -0.21 | N/A | N/A | N/A |
EPS Diluted Continuous Ops | -22.44 | -0.21 | N/A | N/A | N/A |
EPS Diluted Before Non-Recurring Items | -13.98 | N/A | N/A | N/A | N/A |
EBITDA(a) | $-105,798 | $-1,225 | $N/A | $N/A | $N/A |